Your browser doesn't support javascript.
SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
Frieman, Matthew; Harris, Anthony D; Herati, Ramin Sedaghat; Krammer, Florian; Mantovani, Alberto; Rescigno, Maria; Sajadi, Mohammad M; Simon, Viviana.
  • Frieman M; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States. Electronic address: MFrieman@som.umaryland.edu.
  • Harris AD; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States; Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States. Electronic address: aharris@som.umaryland.edu.
  • Herati RS; New York University School of Medicine, New York City, NY, United States. Electronic address: Ramin.Herati@nyulangone.org.
  • Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: florian.krammer@mssm.edu.
  • Mantovani A; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy; The William Harvey Research Institute, Queen Mary University, London, United Kingdom. Electronic address: Alberto.Mantovani@humanitasresearch.it.
  • Rescigno M; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy. Electronic address: maria.rescigno@hunimed.eu.
  • Sajadi MM; Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States; Global Virus Network, Baltimore, Maryland, United States. Electronic address: msajadi@ihv.umaryland.edu
  • Simon V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount S
EBioMedicine ; 68: 103401, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1242922
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Vaccination / Immunization Schedule / Immunization, Secondary / Vaccination / Survivors / Pandemics / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: EBioMedicine Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Vaccination / Immunization Schedule / Immunization, Secondary / Vaccination / Survivors / Pandemics / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: EBioMedicine Year: 2021 Document Type: Article